메뉴 건너뛰기




Volumn 19, Issue 17, 2012, Pages 2689-2702

Iron chelators for the treatment of cancer

Author keywords

3 AP; DFO; Dp44mT; Iron chelation; PIH; Ribonucleotide reductase; Tachpyr

Indexed keywords

3 AMINOPICOLINALDEHYDE THIOSEMICARBAZONE; 5 HYDROXYPICOLINALDEHYDE THIOSEMICARBAZONE; CYTARABINE; DEFERASIROX; DEFEROXAMINE MESYLATE; DI 2 PYRIDYLKETONE 4,4,DIMETHYL 3 THIOSEMICARBAZONE; GEMCITABINE; IRON CHELATING AGENT; NSC 73306; TACHPYR; THIOSEMICARBAZONE; UNCLASSIFIED DRUG;

EID: 84861898212     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800609706     Document Type: Article
Times cited : (163)

References (143)
  • 1
    • 0033599057 scopus 로고    scopus 로고
    • Disorders of iron metabolism
    • Andrews, N.C., Disorders of iron metabolism. N Engl J Med, 1999, 341(26), 1986-1995.
    • (1999) N Engl J Med , vol.341 , Issue.26 , pp. 1986-1995
    • Andrews, N.C.1
  • 2
    • 47249142777 scopus 로고    scopus 로고
    • Iron-sulfur cluster biogenesis and human disease
    • Rouault, T.A.; Tong, W.H., Iron-sulfur cluster biogenesis and human disease. Trends Genet, 2008, 24(8), 398-407.
    • (2008) Trends Genet , vol.24 , Issue.8 , pp. 398-407
    • Rouault, T.A.1    Tong, W.H.2
  • 3
    • 0021891869 scopus 로고
    • The mitochondrial electron transport and oxidative phosphorylation system
    • Hatefi, Y., The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem, 1985, 54, 1015-1069.
    • (1985) Annu Rev Biochem , vol.54 , pp. 1015-1069
    • Hatefi, Y.1
  • 4
    • 44449145862 scopus 로고    scopus 로고
    • Redox signaling and cancer: The role of "labile" iron
    • Galaris, D.; Skiada, V.; Barbouti, A., Redox signaling and cancer: the role of "labile" iron. Cancer Lett, 2008, 266(1), 21-29.
    • (2008) Cancer Lett , vol.266 , Issue.1 , pp. 21-29
    • Galaris, D.1    Skiada, V.2    Barbouti, A.3
  • 5
    • 0034648298 scopus 로고    scopus 로고
    • The haber-weiss reaction and mechanisms of toxicity
    • Kehrer, J.P., The Haber-Weiss reaction and mechanisms of toxicity. Toxicology, 2000, 149(1), 43-50.
    • (2000) Toxicology , vol.149 , Issue.1 , pp. 43-50
    • Kehrer, J.P.1
  • 7
    • 0031567095 scopus 로고    scopus 로고
    • The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
    • Richardson, D.R.; Ponka, P., The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta, 1997, 1331(1), 1-40.
    • (1997) Biochim Biophys Acta , vol.1331 , Issue.1 , pp. 1-40
    • Richardson, D.R.1    Ponka, P.2
  • 9
    • 33846691564 scopus 로고    scopus 로고
    • Iron uptake and metabolism in the new millennium
    • Dunn, L.L.; Rahmanto, Y.S.; Richardson, D.R., Iron uptake and metabolism in the new millennium. Trends Cell Biol, 2007, 17(2), 93-100.
    • (2007) Trends Cell Biol , vol.17 , Issue.2 , pp. 93-100
    • Dunn, L.L.1    Rahmanto, Y.S.2    Richardson, D.R.3
  • 10
    • 73149092511 scopus 로고    scopus 로고
    • Optimizing iron chelation strategies in beta-thalassaemia major
    • Porter, J.B., Optimizing iron chelation strategies in beta-thalassaemia major. Blood Rev, 2009, 23 Suppl 1, S3-7.
    • (2009) Blood Rev , vol.23 , Issue.SUPPL. 1
    • Porter, J.B.1
  • 11
    • 29844457587 scopus 로고    scopus 로고
    • The evolution of iron chelators for the treatment of iron overload disease and cancer
    • Kalinowski, D.S.; Richardson, D.R., The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev, 2005, 57(4), 547-583.
    • (2005) Pharmacol Rev , vol.57 , Issue.4 , pp. 547-583
    • Kalinowski, D.S.1    Richardson, D.R.2
  • 14
    • 0023092624 scopus 로고
    • Antineuroblastoma activity of desferoxamine in human cell lines
    • Blatt, J.; Stitely, S., Antineuroblastoma activity of desferoxamine in human cell lines. Cancer Res, 1987, 47(7), 1749-1750.
    • (1987) Cancer Res , vol.47 , Issue.7 , pp. 1749-1750
    • Blatt, J.1    Stitely, S.2
  • 15
    • 0023689207 scopus 로고
    • Mechanism of antineuroblastoma activity of deferoxamine in vitro
    • Blatt, J.; Taylor, S.R.; Stitely, S., Mechanism of antineuroblastoma activity of deferoxamine in vitro. J Lab Clin Med, 1988, 112(4), 433-436.
    • (1988) J Lab Clin Med , vol.112 , Issue.4 , pp. 433-436
    • Blatt, J.1    Taylor, S.R.2    Stitely, S.3
  • 17
    • 0017127835 scopus 로고
    • Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells
    • Hoffbrand, A.V.; Ganeshaguru, K.; Hooton, J.W.; Tattersall, M.H., Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol, 1976, 33(4), 517-526.
    • (1976) Br J Haematol , vol.33 , Issue.4 , pp. 517-526
    • Hoffbrand, A.V.1    Ganeshaguru, K.2    Hooton, J.W.3    Tattersall, M.H.4
  • 18
    • 0022600935 scopus 로고
    • Iron-induced L1210 cell growth: Evidence of a transferrin-independent iron transport
    • Basset, P.; Quesneau, Y.; Zwiller, J., Iron-induced L1210 cell growth: evidence of a transferrin-independent iron transport. Cancer Res, 1986, 46(4 Pt 1), 1644-1647.
    • (1986) Cancer Res , vol.46 , Issue.4 PART 1 , pp. 1644-1647
    • Basset, P.1    Quesneau, Y.2    Zwiller, J.3
  • 19
    • 0023896498 scopus 로고
    • Growth-stimulating effect of ferric citrate on hybridoma cells: Characterization and relation to transferrin function
    • Kovar, J., Growth-stimulating effect of ferric citrate on hybridoma cells: characterization and relation to transferrin function. Hybridoma, 1988, 7(3), 255-263.
    • (1988) Hybridoma , vol.7 , Issue.3 , pp. 255-263
    • Kovar, J.1
  • 20
    • 0023900767 scopus 로고
    • Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis
    • Laskey, J.; Webb, I.; Schulman, H.M.; Ponka, P., Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp Cell Res, 1988, 176(1), 87-95.
    • (1988) Exp Cell Res , vol.176 , Issue.1 , pp. 87-95
    • Laskey, J.1    Webb, I.2    Schulman, H.M.3    Ponka, P.4
  • 21
    • 0036118607 scopus 로고    scopus 로고
    • The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
    • Kwok, J.C.; Richardson, D.R., The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol, 2002, 42(1), 65-78.
    • (2002) Crit Rev Oncol Hematol , vol.42 , Issue.1 , pp. 65-78
    • Kwok, J.C.1    Richardson, D.R.2
  • 22
    • 2542504483 scopus 로고    scopus 로고
    • Structure, function, and mechanism of ribonucleotide reductases
    • Kolberg, M.; Strand, K.R.; Graff, P.; Andersson, K.K., Structure, function, and mechanism of ribonucleotide reductases. Biochim Biophys Acta, 2004, 1699(1-2), 1-34.
    • (2004) Biochim Biophys Acta , vol.1699 , Issue.1-2 , pp. 1-34
    • Kolberg, M.1    Strand, K.R.2    Graff, P.3    Andersson, K.K.4
  • 23
    • 0022260274 scopus 로고
    • Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits
    • Engstrom, Y.; Eriksson, S.; Jildevik, I.; Skog, S.; Thelander, L.; Tribukait, B., Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem, 1985, 260(16), 9114-9116.
    • (1985) J Biol Chem , vol.260 , Issue.16 , pp. 9114-9116
    • Engstrom, Y.1    Eriksson, S.2    Jildevik, I.3    Skog, S.4    Thelander, L.5    Tribukait, B.6
  • 24
    • 0019459845 scopus 로고
    • Role of ribonucleotide reductase in expression in the neoplastic program
    • Takeda, E.; Weber, G., Role of ribonucleotide reductase in expression in the neoplastic program. Life Sci, 1981, 28(9), 1007-1014.
    • (1981) Life Sci , vol.28 , Issue.9 , pp. 1007-1014
    • Takeda, E.1    Weber, G.2
  • 25
    • 0031938457 scopus 로고    scopus 로고
    • Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
    • Zhou, B.S.; Tsai, P.; Ker, R.; Tsai, J.; Ho, R.; Yu, J.; Shih, J.; Yen, Y., Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential. Clin Exp Metastasis, 1998, 16(1), 43-49.
    • (1998) Clin Exp Metastasis , vol.16 , Issue.1 , pp. 43-49
    • Zhou, B.S.1    Tsai, P.2    Ker, R.3    Tsai, J.4    Ho, R.5    Yu, J.6    Shih, J.7    Yen, Y.8
  • 26
    • 0037009846 scopus 로고    scopus 로고
    • The role of iron in cell cycle progression and the proliferation of neoplastic cells
    • Le, N.T.; Richardson, D.R., The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta, 2002, 1603(1), 31-46.
    • (2002) Biochim Biophys Acta , vol.1603 , Issue.1 , pp. 31-46
    • Le, N.T.1    Richardson, D.R.2
  • 27
    • 33745823841 scopus 로고    scopus 로고
    • Ribonucleotide reductase inhibitors and future drug design
    • Shao, J.; Zhou, B.; Chu, B.; Yen, Y., Ribonucleotide reductase inhibitors and future drug design. Curr Cancer Drug Targets, 2006, 6(5), 409-431.
    • (2006) Curr Cancer Drug Targets , vol.6 , Issue.5 , pp. 409-431
    • Shao, J.1    Zhou, B.2    Chu, B.3    Yen, Y.4
  • 28
    • 0027380398 scopus 로고
    • Reduction and loss of the iron center in the reaction of the small subunit of mouse ribonucleotide reductase with hydroxyurea
    • Nyholm, S.; Thelander, L.; Graslund, A., Reduction and loss of the iron center in the reaction of the small subunit of mouse ribonucleotide reductase with hydroxyurea. Biochemistry, 1993, 32(43), 11569-11574.
    • (1993) Biochemistry , vol.32 , Issue.43 , pp. 11569-11574
    • Nyholm, S.1    Thelander, L.2    Graslund, A.3
  • 29
    • 0031923969 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of hydroxyurea
    • Gwilt, P.R.; Tracewell, W.G., Pharmacokinetics and pharmacodynamics of hydroxyurea. Clin Pharmacokinet, 1998, 34(5), 347-358.
    • (1998) Clin Pharmacokinet , vol.34 , Issue.5 , pp. 347-358
    • Gwilt, P.R.1    Tracewell, W.G.2
  • 30
    • 0018603336 scopus 로고
    • Modulation of cell surface iron transferrin receptors by cellular density and state of activation
    • Larrick, J.W.; Cresswell, P., Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct, 1979, 11(4), 579-586.
    • (1979) J Supramol Struct , vol.11 , Issue.4 , pp. 579-586
    • Larrick, J.W.1    Cresswell, P.2
  • 31
    • 0000302649 scopus 로고
    • Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro
    • Trowbridge, I.S.; Lopez, F., Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci U S A, 1982, 79(4), 1175-1179.
    • (1982) Proc Natl Acad Sci U S A , vol.79 , Issue.4 , pp. 1175-1179
    • Trowbridge, I.S.1    Lopez, F.2
  • 32
    • 0034903090 scopus 로고    scopus 로고
    • Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene
    • Yang, D.C.; Jiang, X.P.; Elliott, R.L.; Head, J.F., Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Anticancer Res, 2001, 21(3B), 1777-1787.
    • (2001) Anticancer Res , vol.21 , Issue.3 B , pp. 1777-1787
    • Yang, D.C.1    Jiang, X.P.2    Elliott, R.L.3    Head, J.F.4
  • 33
    • 0033566305 scopus 로고    scopus 로고
    • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: The effect of the ligands on molecular targets involved in proliferation
    • Darnell, G.; Richardson, D.R., The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation. Blood, 1999, 94(2), 781-792.
    • (1999) Blood , vol.94 , Issue.2 , pp. 781-792
    • Darnell, G.1    Richardson, D.R.2
  • 34
    • 4444248453 scopus 로고    scopus 로고
    • Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: In vitro and in vivo assessment
    • Yuan, J.; Lovejoy, D.B.; Richardson, D.R., Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. Blood, 2004, 104(5), 1450-1458.
    • (2004) Blood , vol.104 , Issue.5 , pp. 1450-1458
    • Yuan, J.1    Lovejoy, D.B.2    Richardson, D.R.3
  • 35
    • 27744528421 scopus 로고    scopus 로고
    • Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer
    • Richardson, D.R., Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer. Curr Med Chem, 2005, 12(23), 2711-2729.
    • (2005) Curr Med Chem , vol.12 , Issue.23 , pp. 2711-2729
    • Richardson, D.R.1
  • 36
    • 0035437183 scopus 로고    scopus 로고
    • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression
    • Gao, J.; Richardson, D.R., The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression. Blood, 2001, 98(3), 842-850.
    • (2001) Blood , vol.98 , Issue.3 , pp. 842-850
    • Gao, J.1    Richardson, D.R.2
  • 37
    • 0030601987 scopus 로고    scopus 로고
    • Iron deprivation inhibits cyclindependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells
    • Kulp, K.S.; Green, S.L.; Vulliet, P.R., Iron deprivation inhibits cyclindependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp Cell Res, 1996, 229(1), 60-68.
    • (1996) Exp Cell Res , vol.229 , Issue.1 , pp. 60-68
    • Kulp, K.S.1    Green, S.L.2    Vulliet, P.R.3
  • 38
    • 0028171292 scopus 로고
    • G1 phase progression: Cycling on cue
    • Sherr, C.J., G1 phase progression: cycling on cue. Cell, 1994, 79(4), 551-555.
    • (1994) Cell , vol.79 , Issue.4 , pp. 551-555
    • Sherr, C.J.1
  • 39
    • 34548286520 scopus 로고    scopus 로고
    • Tuning cell cycle regulation with an iron key
    • Yu, Y.; Kovacevic, Z.; Richardson, D.R., Tuning cell cycle regulation with an iron key. Cell Cycle, 2007, 6(16), 1982-1994.
    • (2007) Cell Cycle , vol.6 , Issue.16 , pp. 1982-1994
    • Yu, Y.1    Kovacevic, Z.2    Richardson, D.R.3
  • 40
    • 77149125234 scopus 로고    scopus 로고
    • Iron chelatormediated alterations in gene expression: Identification of novel ironregulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53
    • Saletta, F.; Rahmanto, Y.S.; Noulsri, E.; Richardson, D.R., Iron chelatormediated alterations in gene expression: identification of novel ironregulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53. Mol Pharmacol, 2010, 77(3), 443-458.
    • (2010) Mol Pharmacol , vol.77 , Issue.3 , pp. 443-458
    • Saletta, F.1    Rahmanto, Y.S.2    Noulsri, E.3    Richardson, D.R.4
  • 41
    • 0034003005 scopus 로고    scopus 로고
    • Stress signals utilize multiple pathways to stabilize p53
    • Ashcroft, M.; Taya, Y.; Vousden, K.H., Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol, 2000, 20(9), 3224-3233.
    • (2000) Mol Cell Biol , vol.20 , Issue.9 , pp. 3224-3233
    • Ashcroft, M.1    Taya, Y.2    Vousden, K.H.3
  • 42
    • 79955462543 scopus 로고    scopus 로고
    • Cellular iron-depletion stimulates the JNK and p38 MAP signaling transduction pathways, dissociation of ASK1- thioredoxin and activation of ASK1
    • Yu, Y.; Richardson, D.R., Cellular iron-depletion stimulates the JNK and p38 MAP signaling transduction pathways, dissociation of ASK1- thioredoxin and activation of ASK1. J Biol Chem, 2011, 286(17), 15413-15427.
    • (2011) J Biol Chem , vol.286 , Issue.17 , pp. 15413-15427
    • Yu, Y.1    Richardson, D.R.2
  • 43
    • 34547137681 scopus 로고    scopus 로고
    • Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclindependent kinase inhibitor p21CIP1/WAF1 by iron depletion
    • Fu, D.; Richardson, D.R., Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclindependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood, 2007, 110(2), 752-761.
    • (2007) Blood , vol.110 , Issue.2 , pp. 752-761
    • Fu, D.1    Richardson, D.R.2
  • 44
    • 0742304154 scopus 로고    scopus 로고
    • Regulation of p27(Kip1) by intracellular iron levels
    • Wang, G.; Miskimins, R.; Miskimins, W.K., Regulation of p27(Kip1) by intracellular iron levels. Biometals, 2004, 17(1), 15-24.
    • (2004) Biometals , vol.17 , Issue.1 , pp. 15-24
    • Wang, G.1    Miskimins, R.2    Miskimins, W.K.3
  • 48
    • 18244390251 scopus 로고    scopus 로고
    • Drg1 expression in 131 colorectal liver metastases: Correlation with clinical variables and patient outcomes
    • Shah, M.A.; Kemeny, N.; Hummer, A.; Drobnjak, M.; Motwani, M.; Cordon-Cardo, C.; Gonen, M.; Schwartz, G.K., Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin Cancer Res, 2005, 11(9), 3296-3302.
    • (2005) Clin Cancer Res , vol.11 , Issue.9 , pp. 3296-3302
    • Shah, M.A.1    Kemeny, N.2    Hummer, A.3    Drobnjak, M.4    Motwani, M.5    Cordon-Cardo, C.6    Gonen, M.7    Schwartz, G.K.8
  • 49
    • 33745700194 scopus 로고    scopus 로고
    • Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis
    • Maruyama, Y.; Ono, M.; Kawahara, A.; Yokoyama, T.; Basaki, Y.; Kage, M.; Aoyagi, S.; Kinoshita, H.; Kuwano, M., Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res, 2006, 66(12), 6233-6242.
    • (2006) Cancer Res , vol.66 , Issue.12 , pp. 6233-6242
    • Maruyama, Y.1    Ono, M.2    Kawahara, A.3    Yokoyama, T.4    Basaki, Y.5    Kage, M.6    Aoyagi, S.7    Kinoshita, H.8    Kuwano, M.9
  • 50
    • 79955770381 scopus 로고    scopus 로고
    • The metastasis suppressor, N-MYC downstream regulated gene 1 (NDRG1), UP-regulates P21 VIA P53-independent mechanisms
    • Kovacevic, Z.; Sivagurunathan, S.; Mangs, H.; Chikhani, S.; Zhang, D.; Richardson, D.R., The metastasis suppressor, N-MYC downstream regulated gene 1 (NDRG1), UP-regulates P21 VIA P53-independent mechanisms. Carcinogenesis, 2011, 32(5), 732-740.
    • (2011) Carcinogenesis , vol.32 , Issue.5 , pp. 732-740
    • Kovacevic, Z.1    Sivagurunathan, S.2    Mangs, H.3    Chikhani, S.4    Zhang, D.5    Richardson, D.R.6
  • 51
    • 34248583886 scopus 로고    scopus 로고
    • MAP kinase signalling pathways in cancer
    • Dhillon, A.S.; Hagan, S.; Rath, O.; Kolch, W., MAP kinase signalling pathways in cancer. Oncogene, 2007, 26(22), 3279-3290.
    • (2007) Oncogene , vol.26 , Issue.22 , pp. 3279-3290
    • Dhillon, A.S.1    Hagan, S.2    Rath, O.3    Kolch, W.4
  • 52
    • 0033729838 scopus 로고    scopus 로고
    • Control of the eukaryotic cell cycle by MAP kinase signaling pathways
    • Wilkinson, M.G.; Millar, J.B., Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J, 2000, 14(14), 2147-2157.
    • (2000) FASEB J , vol.14 , Issue.14 , pp. 2147-2157
    • Wilkinson, M.G.1    Millar, J.B.2
  • 53
    • 0023905712 scopus 로고
    • Cloning and expression of two genes of Streptomyces pilosus involved in the biosynthesis of the siderophore desferrioxamine B
    • Schupp, T.; Toupet, C.; Divers, M., Cloning and expression of two genes of Streptomyces pilosus involved in the biosynthesis of the siderophore desferrioxamine B. Gene, 1988, 64(2), 179-188.
    • (1988) Gene , vol.64 , Issue.2 , pp. 179-188
    • Schupp, T.1    Toupet, C.2    Divers, M.3
  • 54
    • 0042384674 scopus 로고    scopus 로고
    • Iron chelators and iron toxicity
    • Brittenham, G.M., Iron chelators and iron toxicity. Alcohol, 2003, 30(2), 151-158.
    • (2003) Alcohol , vol.30 , Issue.2 , pp. 151-158
    • Brittenham, G.M.1
  • 55
    • 7444249085 scopus 로고
    • The biochemistry of desferrioxamine and its relation to iron metabolism
    • Keberle, H., The Biochemistry of Desferrioxamine and Its Relation to Iron Metabolism. Ann N Y Acad Sci, 1964, 119, 758-768.
    • (1964) Ann N y Acad Sci , vol.119 , pp. 758-768
    • Keberle, H.1
  • 56
    • 0036888008 scopus 로고    scopus 로고
    • Chemical aspects of siderophore mediated iron transport
    • Boukhalfa, H.; Crumbliss, A.L., Chemical aspects of siderophore mediated iron transport. Biometals, 2002, 15(4), 325-339.
    • (2002) Biometals , vol.15 , Issue.4 , pp. 325-339
    • Boukhalfa, H.1    Crumbliss, A.L.2
  • 57
    • 0028158768 scopus 로고
    • The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell
    • Richardson, D.; Ponka, P.; Baker, E., The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res, 1994, 54(3), 685-689.
    • (1994) Cancer Res , vol.54 , Issue.3 , pp. 685-689
    • Richardson, D.1    Ponka, P.2    Baker, E.3
  • 58
    • 0026575576 scopus 로고
    • Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2- hydroxy-1-naphthylaldehyde using the hepatocyte in culture
    • Baker, E.; Richardson, D.; Gross, S.; Ponka, P., Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2- hydroxy-1-naphthylaldehyde using the hepatocyte in culture. Hepatology, 1992, 15(3), 492-501.
    • (1992) Hepatology , vol.15 , Issue.3 , pp. 492-501
    • Baker, E.1    Richardson, D.2    Gross, S.3    Ponka, P.4
  • 59
  • 60
    • 77952557403 scopus 로고    scopus 로고
    • The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice
    • Zhang, W.J.; Wei, H.; Frei, B., The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice. Exp Biol Med (Maywood), 2010, 235(5), 633-641.
    • (2010) Exp Biol Med (Maywood) , vol.235 , Issue.5 , pp. 633-641
    • Zhang, W.J.1    Wei, H.2    Frei, B.3
  • 61
    • 0031001278 scopus 로고    scopus 로고
    • Iron-chelating therapy and the treatment of thalassemia
    • Olivieri, N.F.; Brittenham, G.M., Iron-chelating therapy and the treatment of thalassemia. Blood, 1997, 89(3), 739-761.
    • (1997) Blood , vol.89 , Issue.3 , pp. 739-761
    • Olivieri, N.F.1    Brittenham, G.M.2
  • 63
    • 0028585886 scopus 로고
    • Deferoxamine in children with recurrent neuroblastoma
    • Blatt, J., Deferoxamine in children with recurrent neuroblastoma. Anticancer Res, 1994, 14(5B), 2109-2112.
    • (1994) Anticancer Res , vol.14 , Issue.5 B , pp. 2109-2112
    • Blatt, J.1
  • 64
    • 0029066979 scopus 로고
    • Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary results. italian neuroblastoma cooperative group
    • Donfrancesco, A.; De Bernardi, B.; Carli, M.; Mancini, A.; Nigro, M.; De Sio, L.; Casale, F.; Bagnulo, S.; Helson, L.; Deb, G., Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group. Eur J Cancer, 1995, 31A(4), 612-615.
    • (1995) Eur J Cancer , vol.31 A , Issue.4 , pp. 612-615
    • Donfrancesco, A.1    De Bernardi, B.2    Carli, M.3    Mancini, A.4    Nigro, M.5    De Sio, L.6    Casale, F.7    Bagnulo, S.8    Helson, L.9    Deb, G.10
  • 65
    • 3042513348 scopus 로고    scopus 로고
    • The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes
    • Beraldo, H.; Gambino, D., The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. Mini Rev Med Chem, 2004, 4(1), 31-39.
    • (2004) Mini Rev Med Chem , vol.4 , Issue.1 , pp. 31-39
    • Beraldo, H.1    Gambino, D.2
  • 66
    • 0017239192 scopus 로고
    • Inhibition of tumor cell transplantability by iron and copper complexes of 5-substituted 2- formylpyridine thiosemicarbazones
    • Antholine, W.E.; Knight, J.M.; Petering, D.H., Inhibition of tumor cell transplantability by iron and copper complexes of 5-substituted 2- formylpyridine thiosemicarbazones. J Med Chem, 1976, 19(2), 339-341.
    • (1976) J Med Chem , vol.19 , Issue.2 , pp. 339-341
    • Antholine, W.E.1    Knight, J.M.2    Petering, D.H.3
  • 68
    • 0037237032 scopus 로고    scopus 로고
    • Examination of the antiproliferative activity of iron chelators: Multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311
    • Chaston, T.B.; Lovejoy, D.B.; Watts, R.N.; Richardson, D.R., Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311. Clin Cancer Res, 2003, 9(1), 402-414.
    • (2003) Clin Cancer Res , vol.9 , Issue.1 , pp. 402-414
    • Chaston, T.B.1    Lovejoy, D.B.2    Watts, R.N.3    Richardson, D.R.4
  • 69
    • 33645473324 scopus 로고    scopus 로고
    • A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase
    • Shao, J.; Zhou, B.; Di Bilio, A.J.; Zhu, L.; Wang, T.; Qi, C.; Shih, J.; Yen, Y., A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase. Mol Cancer Ther, 2006, 5(3), 586-592.
    • (2006) Mol Cancer Ther , vol.5 , Issue.3 , pp. 586-592
    • Shao, J.1    Zhou, B.2    Di Bilio, A.J.3    Zhu, L.4    Wang, T.5    Qi, C.6    Shih, J.7    Yen, Y.8
  • 70
    • 33750471953 scopus 로고    scopus 로고
    • Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
    • Richardson, D.R.; Sharpe, P.C.; Lovejoy, D.B.; Senaratne, D.; Kalinowski, D.S.; Islam, M.; Bernhardt, P.V., Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. J Med Chem, 2006, 49(22), 6510-6521.
    • (2006) J Med Chem , vol.49 , Issue.22 , pp. 6510-6521
    • Richardson, D.R.1    Sharpe, P.C.2    Lovejoy, D.B.3    Senaratne, D.4    Kalinowski, D.S.5    Islam, M.6    Bernhardt, P.V.7
  • 71
    • 0032832996 scopus 로고    scopus 로고
    • Triapine (3- aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): An inhibitor of ribonucleotide reductase with antineoplastic activity
    • Finch, R.A.; Liu, M.C.; Cory, A.H.; Cory, J.G.; Sartorelli, A.C., Triapine (3- aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity. Adv Enzyme Regul, 1999, 39, 3-12.
    • (1999) Adv Enzyme Regul , vol.39 , pp. 3-12
    • Finch, R.A.1    Liu, M.C.2    Cory, A.H.3    Cory, J.G.4    Sartorelli, A.C.5
  • 72
    • 34547562971 scopus 로고    scopus 로고
    • Design, synthesis, and characterization of novel iron chelators: Structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents
    • Kalinowski, D.S.; Yu, Y.; Sharpe, P.C.; Islam, M.; Liao, Y.T.; Lovejoy, D.B.; Kumar, N.; Bernhardt, P.V.; Richardson, D.R., Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents. J Med Chem, 2007, 50(15), 3716-3729.
    • (2007) J Med Chem , vol.50 , Issue.15 , pp. 3716-3729
    • Kalinowski, D.S.1    Yu, Y.2    Sharpe, P.C.3    Islam, M.4    Liao, Y.T.5    Lovejoy, D.B.6    Kumar, N.7    Bernhardt, P.V.8    Richardson, D.R.9
  • 73
    • 84961008985 scopus 로고
    • Observations on the antileukemic activity of pyridine-2-carboxaldehyde thiosemicarbazone and thiocarbohydrazone
    • Brockman, R.W.; Thomson, J.R.; Bell, M.J.; Skipper, H.E., Observations on the antileukemic activity of pyridine-2-carboxaldehyde thiosemicarbazone and thiocarbohydrazone. Cancer Res, 1956, 16(2), 167-170.
    • (1956) Cancer Res , vol.16 , Issue.2 , pp. 167-170
    • Brockman, R.W.1    Thomson, J.R.2    Bell, M.J.3    Skipper, H.E.4
  • 75
    • 0029833706 scopus 로고    scopus 로고
    • The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase
    • Cooper, C.E.; Lynagh, G.R.; Hoyes, K.P.; Hider, R.C.; Cammack, R.; Porter, J.B., The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J Biol Chem, 1996, 271(34), 20291-20299.
    • (1996) J Biol Chem , vol.271 , Issue.34 , pp. 20291-20299
    • Cooper, C.E.1    Lynagh, G.R.2    Hoyes, K.P.3    Hider, R.C.4    Cammack, R.5    Porter, J.B.6
  • 76
    • 0033975268 scopus 로고    scopus 로고
    • Triapine (3-aminopyridine-2-carboxaldehydethiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity
    • Finch, R.A.; Liu, M.; Grill, S.P.; Rose, W.C.; Loomis, R.; Vasquez, K.M.; Cheng, Y.; Sartorelli, A.C., Triapine (3-aminopyridine-2- carboxaldehydethiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Biochem Pharmacol, 2000, 59(8), 983-991.
    • (2000) Biochem Pharmacol , vol.59 , Issue.8 , pp. 983-991
    • Finch, R.A.1    Liu, M.2    Grill, S.P.3    Rose, W.C.4    Loomis, R.5    Vasquez, K.M.6    Cheng, Y.7    Sartorelli, A.C.8
  • 77
    • 0035181433 scopus 로고    scopus 로고
    • Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: Effect on the R2 subunit of ribonucleotide reductase
    • Green, D.A.; Antholine, W.E.; Wong, S.J.; Richardson, D.R.; Chitambar, C.R., Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase. Clin Cancer Res, 2001, 7(11), 3574-3579.
    • (2001) Clin Cancer Res , vol.7 , Issue.11 , pp. 3574-3579
    • Green, D.A.1    Antholine, W.E.2    Wong, S.J.3    Richardson, D.R.4    Chitambar, C.R.5
  • 79
    • 0141455148 scopus 로고    scopus 로고
    • Phase i and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors
    • Murren, J.; Modiano, M.; Clairmont, C.; Lambert, P.; Savaraj, N.; Doyle, T.; Sznol, M., Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors. Clin Cancer Res, 2003, 9(11), 4092-4100.
    • (2003) Clin Cancer Res , vol.9 , Issue.11 , pp. 4092-4100
    • Murren, J.1    Modiano, M.2    Clairmont, C.3    Lambert, P.4    Savaraj, N.5    Doyle, T.6    Sznol, M.7
  • 80
    • 40549137513 scopus 로고    scopus 로고
    • A multicenter phase II trial of 3- aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
    • Ma, B.; Goh, B.C.; Tan, E.H.; Lam, K.C.; Soo, R.; Leong, S.S.; Wang, L.Z.; Mo, F.; Chan, A.T.; Zee, B.; Mok, T., A multicenter phase II trial of 3- aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Invest New Drugs, 2008, 26(2), 169-173.
    • (2008) Invest New Drugs , vol.26 , Issue.2 , pp. 169-173
    • Ma, B.1    Goh, B.C.2    Tan, E.H.3    Lam, K.C.4    Soo, R.5    Leong, S.S.6    Wang, L.Z.7    Mo, F.8    Chan, A.T.9    Zee, B.10    Mok, T.11
  • 81
    • 34547687556 scopus 로고    scopus 로고
    • Phase ii study of triapine in patients with metastatic renal cell carcinoma: A trial of the national cancer institute of canada clinical trials group (ncic ind.161)
    • Knox, J.J.; Hotte, S.J.; Kollmannsberger, C.; Winquist, E.; Fisher, B.; Eisenhauer, E.A., Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161). Invest New Drugs, 2007, 25(5), 471-477.
    • (2007) Invest New Drugs , vol.25 , Issue.5 , pp. 471-477
    • Knox, J.J.1    Hotte, S.J.2    Kollmannsberger, C.3    Winquist, E.4    Fisher, B.5    Eisenhauer, E.A.6
  • 82
    • 74149093251 scopus 로고    scopus 로고
    • A phase ii trial of triapine (nsc# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern cooperative oncology group study 1503
    • Traynor, A.M.; Lee, J.W.; Bayer, G.K.; Tate, J.M.; Thomas, S.P.; Mazurczak, M.; Graham, D.L.; Kolesar, J.M.; Schiller, J.H., A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503. Invest New Drugs, 2010, 28(1), 91-97.
    • (2010) Invest New Drugs , vol.28 , Issue.1 , pp. 91-97
    • Traynor, A.M.1    Lee, J.W.2    Bayer, G.K.3    Tate, J.M.4    Thomas, S.P.5    Mazurczak, M.6    Graham, D.L.7    Kolesar, J.M.8    Schiller, J.H.9
  • 83
    • 0018394556 scopus 로고
    • Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent
    • Ponka, P.; Borova, J.; Neuwirt, J.; Fuchs, O., Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent. FEBS Lett, 1979, 97(2), 317-321.
    • (1979) FEBS Lett , vol.97 , Issue.2 , pp. 317-321
    • Ponka, P.1    Borova, J.2    Neuwirt, J.3    Fuchs, O.4
  • 84
    • 0041808760 scopus 로고    scopus 로고
    • Pyridoxal isonicotinoyl hydrazone and its analogues
    • Buss, J.L.; Hermes-Lima, M.; Ponka, P., Pyridoxal isonicotinoyl hydrazone and its analogues. Adv Exp Med Biol, 2002, 509, 205-229.
    • (2002) Adv Exp Med Biol , vol.509 , pp. 205-229
    • Buss, J.L.1    Hermes-Lima, M.2    Ponka, P.3
  • 85
    • 0037114461 scopus 로고    scopus 로고
    • Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes
    • Buss, J.L.; Arduini, E.; Ponka, P., Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes. Biochem Pharmacol, 2002, 64(12), 1689-1701.
    • (2002) Biochem Pharmacol , vol.64 , Issue.12 , pp. 1689-1701
    • Buss, J.L.1    Arduini, E.2    Ponka, P.3
  • 86
    • 0028891974 scopus 로고
    • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents
    • Richardson, D.R.; Tran, E.H.; Ponka, P., The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Blood, 1995, 86(11), 4295-4306.
    • (1995) Blood , vol.86 , Issue.11 , pp. 4295-4306
    • Richardson, D.R.1    Tran, E.H.2    Ponka, P.3
  • 87
    • 0018567483 scopus 로고
    • Effective iron chelation following oral administration of an isoniazid-pyridoxal hydrazone
    • Hoy, T.; Humphrys, J.; Jacobs, A.; Williams, A.; Ponka, P., Effective iron chelation following oral administration of an isoniazid-pyridoxal hydrazone. Br J Haematol, 1979, 43(3), 443-449.
    • (1979) Br J Haematol , vol.43 , Issue.3 , pp. 443-449
    • Hoy, T.1    Humphrys, J.2    Jacobs, A.3    Williams, A.4    Ponka, P.5
  • 88
    • 0032771646 scopus 로고    scopus 로고
    • Crystal and molecular structure of 2- hydroxy-1-naphthaldehyde isonicotinoyl hydrazone (NIH) and its iron(III) complex: An iron chelator with anti-tumour activity
    • Richardson, D.R.; Bernhardt, P.V., Crystal and molecular structure of 2- hydroxy-1-naphthaldehyde isonicotinoyl hydrazone (NIH) and its iron(III) complex: an iron chelator with anti-tumour activity. J Biol Inorg Chem, 1999, 4(3), 266-273.
    • (1999) J Biol Inorg Chem , vol.4 , Issue.3 , pp. 266-273
    • Richardson, D.R.1    Bernhardt, P.V.2
  • 89
    • 33748784061 scopus 로고    scopus 로고
    • Caged-iron chelators a novel approach towards protecting skin cells against UVA-induced necrotic cell death
    • Yiakouvaki, A.; Savovic, J.; Al-Qenaei, A.; Dowden, J.; Pourzand, C., Caged-iron chelators a novel approach towards protecting skin cells against UVA-induced necrotic cell death. J Invest Dermatol, 2006, 126(10), 2287-2295.
    • (2006) J Invest Dermatol , vol.126 , Issue.10 , pp. 2287-2295
    • Yiakouvaki, A.1    Savovic, J.2    Al-Qenaei, A.3    Dowden, J.4    Pourzand, C.5
  • 90
    • 58149479414 scopus 로고    scopus 로고
    • Treatment of iron overload in thalassemia
    • Cianciulli, P., Treatment of iron overload in thalassemia. Pediatr Endocrinol Rev, 2008, 6 Suppl 1, 208-213.
    • (2008) Pediatr Endocrinol Rev , vol.6 , Issue.SUPPL. 1 , pp. 208-213
    • Cianciulli, P.1
  • 91
    • 33745261785 scopus 로고    scopus 로고
    • The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox
    • Chantrel-Groussard, K.; Gaboriau, F.; Pasdeloup, N.; Havouis, R.; Nick, H.; Pierre, J.L.; Brissot, P.; Lescoat, G., The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox. Eur J Pharmacol, 2006, 541(3), 129-137.
    • (2006) Eur J Pharmacol , vol.541 , Issue.3 , pp. 129-137
    • Chantrel-Groussard, K.1    Gaboriau, F.2    Pasdeloup, N.3    Havouis, R.4    Nick, H.5    Pierre, J.L.6    Brissot, P.7    Lescoat, G.8
  • 93
    • 0035886024 scopus 로고    scopus 로고
    • Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells
    • Guzman, M.L.; Neering, S.J.; Upchurch, D.; Grimes, B.; Howard, D.S.; Rizzieri, D.A.; Luger, S.M.; Jordan, C.T., Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood, 2001, 98(8), 2301-2307.
    • (2001) Blood , vol.98 , Issue.8 , pp. 2301-2307
    • Guzman, M.L.1    Neering, S.J.2    Upchurch, D.3    Grimes, B.4    Howard, D.S.5    Rizzieri, D.A.6    Luger, S.M.7    Jordan, C.T.8
  • 94
    • 65349129409 scopus 로고    scopus 로고
    • The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
    • Ohyashiki, J.H.; Kobayashi, C.; Hamamura, R.; Okabe, S.; Tauchi, T.; Ohyashiki, K., The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1. Cancer Sci, 2009, 100(5), 970-977.
    • (2009) Cancer Sci , vol.100 , Issue.5 , pp. 970-977
    • Ohyashiki, J.H.1    Kobayashi, C.2    Hamamura, R.3    Okabe, S.4    Tauchi, T.5    Ohyashiki, K.6
  • 95
    • 78650510609 scopus 로고    scopus 로고
    • MTOR: From growth signal integration to cancer, diabetes and ageing
    • Zoncu, R.; Efeyan, A.; Sabatini, D.M., mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol, 2011, 12(1), 21-35.
    • (2011) Nat Rev Mol Cell Biol , vol.12 , Issue.1 , pp. 21-35
    • Zoncu, R.1    Efeyan, A.2    Sabatini, D.M.3
  • 99
    • 4744345552 scopus 로고    scopus 로고
    • Synthesis and potent antitumor activities of novel 1,3,5-cis,cis- triaminocyclohexane Npyridyl derivatives
    • Chong, H.S.; Torti, S.V.; Ma, R.; Torti, F.M.; Brechbiel, M.W., Synthesis and potent antitumor activities of novel 1,3,5-cis,cis-triaminocyclohexane Npyridyl derivatives. J Med Chem, 2004, 47(21), 5230-5234.
    • (2004) J Med Chem , vol.47 , Issue.21 , pp. 5230-5234
    • Chong, H.S.1    Torti, S.V.2    Ma, R.3    Torti, F.M.4    Brechbiel, M.W.5
  • 100
    • 0037615112 scopus 로고    scopus 로고
    • Monoclonal antibody drug immunoconjugates for targeted treatment of cancer
    • Trail, P.A.; King, H.D.; Dubowchik, G.M., Monoclonal antibody drug immunoconjugates for targeted treatment of cancer. Cancer Immunol Immunother, 2003, 52(5), 328-337.
    • (2003) Cancer Immunol Immunother , vol.52 , Issue.5 , pp. 328-337
    • Trail, P.A.1    King, H.D.2    Dubowchik, G.M.3
  • 101
    • 33749515083 scopus 로고    scopus 로고
    • A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
    • Whitnall, M.; Howard, J.; Ponka, P.; Richardson, D.R., A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc Natl Acad Sci U S A, 2006, 103(40), 14901-14906.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.40 , pp. 14901-14906
    • Whitnall, M.1    Howard, J.2    Ponka, P.3    Richardson, D.R.4
  • 102
    • 80053926659 scopus 로고    scopus 로고
    • Bp44mT: An orally active chelator of the thiosemicarbazone class with potent anti-tumor efficacy
    • Yu, Y.; Rahmanto, Y.S.; Richardson, D.R., Bp44mT: An orally active chelator of the thiosemicarbazone class with potent anti-tumor efficacy. Br J Pharmacol, 2012, 165(1), 148-166.
    • (2012) Br J Pharmacol , vol.165 , Issue.1 , pp. 148-166
    • Yu, Y.1    Rahmanto, Y.S.2    Richardson, D.R.3
  • 103
    • 79955391641 scopus 로고    scopus 로고
    • The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: An EPR study
    • Jansson, P.J.; Hawkins, C.L.; Lovejoy, D.B.; Richardson, D.R., The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR study. J Inorg Biochem, 2010, 104(11), 1224-1228.
    • (2010) J Inorg Biochem , vol.104 , Issue.11 , pp. 1224-1228
    • Jansson, P.J.1    Hawkins, C.L.2    Lovejoy, D.B.3    Richardson, D.R.4
  • 104
    • 79956293094 scopus 로고    scopus 로고
    • The potent and novel thiosemicarbazone chelators, dp44mt and bp44mt, affect crucial thiol systems required for ribonucleotide reductase activity
    • Yu, Y.; Suryo Rahmanto, Y.; Hawkins, C.L.; Richardson, D.R., The Potent and Novel Thiosemicarbazone Chelators, Dp44mT and Bp44mT, Affect Crucial Thiol Systems Required for Ribonucleotide Reductase Activity. Mol Pharmacol, 2011, 79(6), 921-931.
    • (2011) Mol Pharmacol , vol.79 , Issue.6 , pp. 921-931
    • Yu, Y.1    Suryo Rahmanto, Y.2    Hawkins, C.L.3    Richardson, D.R.4
  • 105
    • 0024393963 scopus 로고
    • Thioredoxin and glutaredoxin systems
    • Holmgren, A., Thioredoxin and glutaredoxin systems. J Biol Chem, 1989, 264(24), 13963-13966.
    • (1989) J Biol Chem , vol.264 , Issue.24 , pp. 13963-13966
    • Holmgren, A.1
  • 106
    • 2342447940 scopus 로고    scopus 로고
    • The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells
    • Chen, J.; Huang, Y.W.; Liu, G.; Afrasiabi, Z.; Sinn, E.; Padhye, S.; Ma, Y., The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells. Toxicol Appl Pharmacol, 2004, 197(1), 40-48.
    • (2004) Toxicol Appl Pharmacol , vol.197 , Issue.1 , pp. 40-48
    • Chen, J.1    Huang, Y.W.2    Liu, G.3    Afrasiabi, Z.4    Sinn, E.5    Padhye, S.6    Ma, Y.7
  • 107
    • 59149089078 scopus 로고    scopus 로고
    • The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells
    • Rao, V.A.; Klein, S.R.; Agama, K.K.; Toyoda, E.; Adachi, N.; Pommier, Y.; Shacter, E.B., The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells. Cancer Res, 2009, 69(3), 948-957.
    • (2009) Cancer Res , vol.69 , Issue.3 , pp. 948-957
    • Rao, V.A.1    Klein, S.R.2    Agama, K.K.3    Toyoda, E.4    Adachi, N.5    Pommier, Y.6    Shacter, E.B.7
  • 110
    • 66249134216 scopus 로고    scopus 로고
    • Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells
    • Hall, M.D.; Salam, N.K.; Hellawell, J.L.; Fales, H.M.; Kensler, C.B.; Ludwig, J.A.; Szakacs, G.; Hibbs, D.E.; Gottesman, M.M., Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem, 2009, 52(10), 3191-3204.
    • (2009) J Med Chem , vol.52 , Issue.10 , pp. 3191-3204
    • Hall, M.D.1    Salam, N.K.2    Hellawell, J.L.3    Fales, H.M.4    Kensler, C.B.5    Ludwig, J.A.6    Szakacs, G.7    Hibbs, D.E.8    Gottesman, M.M.9
  • 111
    • 36448937511 scopus 로고    scopus 로고
    • Deferiprone in the treatment of transfusion-dependent thalassemia: A review and perspective
    • Galanello, R., Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective. Ther Clin Risk Manag, 2007, 3(5), 795-805.
    • (2007) Ther Clin Risk Manag , vol.3 , Issue.5 , pp. 795-805
    • Galanello, R.1
  • 114
    • 0022197562 scopus 로고
    • Thrombocytopenia associated with intravenous desferrioxamine
    • Walker, J.A.; Sherman, R.A.; Eisinger, R.P., Thrombocytopenia associated with intravenous desferrioxamine. Am J Kidney Dis, 1985, 6(4), 254-256.
    • (1985) Am J Kidney Dis , vol.6 , Issue.4 , pp. 254-256
    • Walker, J.A.1    Sherman, R.A.2    Eisinger, R.P.3
  • 116
    • 0023950469 scopus 로고
    • In vitro cytotoxicity of deferoxamine on human marrow haematopoietic progenitors
    • Estrov, Z.; Cohen, A.; Gelfand, E.W.; Freedman, M.H., In vitro cytotoxicity of deferoxamine on human marrow haematopoietic progenitors. Toxicol In Vitro, 1988, 2(2), 131-134.
    • (1988) Toxicol in Vitro , vol.2 , Issue.2 , pp. 131-134
    • Estrov, Z.1    Cohen, A.2    Gelfand, E.W.3    Freedman, M.H.4
  • 117
    • 77649159219 scopus 로고    scopus 로고
    • Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases
    • Kontoghiorghes, G.J.; Kolnagou, A.; Peng, C.T.; Shah, S.V.; Aessopos, A., Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases. Expert Opin Drug Saf, 2010, 9(2), 201-206.
    • (2010) Expert Opin Drug Saf , vol.9 , Issue.2 , pp. 201-206
    • Kontoghiorghes, G.J.1    Kolnagou, A.2    Peng, C.T.3    Shah, S.V.4    Aessopos, A.5
  • 120
    • 59249086968 scopus 로고    scopus 로고
    • Current status in iron chelation in hemoglobinopathies
    • Cappellini, M.D.; Piga, A., Current status in iron chelation in hemoglobinopathies. Curr Mol Med, 2008, 8(7), 663-674.
    • (2008) Curr Mol Med , vol.8 , Issue.7 , pp. 663-674
    • Cappellini, M.D.1    Piga, A.2
  • 121
    • 77649166873 scopus 로고    scopus 로고
    • The impact of desferrioxamine postallogeneic hematopoietic cell transplantation in relapse incidence and disease-free survival: A retrospective analysis
    • Kaloyannidis, P.; Yannaki, E.; Sakellari, I.; Bitzioni, E.; Athanasiadou, A.; Mallouri, D.; Anagnostopoulos, A., The impact of desferrioxamine postallogeneic hematopoietic cell transplantation in relapse incidence and disease-free survival: a retrospective analysis. Transplantation, 2010, 89(4), 472-479.
    • (2010) Transplantation , vol.89 , Issue.4 , pp. 472-479
    • Kaloyannidis, P.1    Yannaki, E.2    Sakellari, I.3    Bitzioni, E.4    Athanasiadou, A.5    Mallouri, D.6    Anagnostopoulos, A.7
  • 122
    • 0023629091 scopus 로고
    • Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells
    • Kaplinsky, C.; Estrov, Z.; Freedman, M.H.; Gelfand, E.W.; Cohen, A., Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells. Leukemia, 1987, 1(5), 437-441.
    • (1987) Leukemia , vol.1 , Issue.5 , pp. 437-441
    • Kaplinsky, C.1    Estrov, Z.2    Freedman, M.H.3    Gelfand, E.W.4    Cohen, A.5
  • 123
    • 0021259518 scopus 로고
    • Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation
    • Lederman, H.M.; Cohen, A.; Lee, J.W.; Freedman, M.H.; Gelfand, E.W., Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood, 1984, 64(3), 748-753.
    • (1984) Blood , vol.64 , Issue.3 , pp. 748-753
    • Lederman, H.M.1    Cohen, A.2    Lee, J.W.3    Freedman, M.H.4    Gelfand, E.W.5
  • 124
    • 0033233243 scopus 로고    scopus 로고
    • Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1
    • Semenza, G.L., Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu Rev Cell Dev Biol, 1999, 15, 551-578.
    • (1999) Annu Rev Cell Dev Biol , vol.15 , pp. 551-578
    • Semenza, G.L.1
  • 125
    • 0035917313 scopus 로고    scopus 로고
    • HIFalpha targeted for VHLmediated destruction by proline hydroxylation: Implications for O2 sensing
    • Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J.M.; Lane, W.S.; Kaelin, W.G., Jr., HIFalpha targeted for VHLmediated destruction by proline hydroxylation: implications for O2 sensing. Science, 2001, 292(5516), 464-468.
    • (2001) Science , vol.292 , Issue.5516 , pp. 464-468
    • Ivan, M.1    Kondo, K.2    Yang, H.3    Kim, W.4    Valiando, J.5    Ohh, M.6    Salic, A.7    Asara, J.M.8    Lane, W.S.9    Kaelin Jr., W.G.10
  • 126
    • 0030859287 scopus 로고    scopus 로고
    • A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex
    • Eguchi, H.; Ikuta, T.; Tachibana, T.; Yoneda, Y.; Kawajiri, K., A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J Biol Chem, 1997, 272(28), 17640-17647.
    • (1997) J Biol Chem , vol.272 , Issue.28 , pp. 17640-17647
    • Eguchi, H.1    Ikuta, T.2    Tachibana, T.3    Yoneda, Y.4    Kawajiri, K.5
  • 127
    • 0034920196 scopus 로고    scopus 로고
    • Hypoxia regulation of gene transcription
    • Caro, J., Hypoxia regulation of gene transcription. High Alt Med Biol, 2001, 2(2), 145-154.
    • (2001) High Alt Med Biol , vol.2 , Issue.2 , pp. 145-154
    • Caro, J.1
  • 128
    • 0032100732 scopus 로고    scopus 로고
    • HIF-1 alpha is required for solid tumor formation and embryonic vascularization
    • Ryan, H.E.; Lo, J.; Johnson, R.S., HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J, 1998, 17(11), 3005-3015.
    • (1998) EMBO J , vol.17 , Issue.11 , pp. 3005-3015
    • Ryan, H.E.1    Lo, J.2    Johnson, R.S.3
  • 129
    • 7244239197 scopus 로고    scopus 로고
    • Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: A link between iron metabolism and proliferation
    • Le, N.T.; Richardson, D.R., Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood, 2004, 104(9), 2967-2975.
    • (2004) Blood , vol.104 , Issue.9 , pp. 2967-2975
    • Le, N.T.1    Richardson, D.R.2
  • 130
  • 132
    • 77956225836 scopus 로고    scopus 로고
    • The maximum tolerated dose and biologic effects of 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors
    • Choi, B.S.; Alberti, D.B.; Schelman, W.R.; Kolesar, J.M.; Thomas, J.P.; Marnocha, R.; Eickhoff, J.C.; Ivy, S.P.; Wilding, G.; Holen, K.D., The maximum tolerated dose and biologic effects of 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors. Cancer Chemother Pharmacol, 2010, 66(5), 973-980.
    • (2010) Cancer Chemother Pharmacol , vol.66 , Issue.5 , pp. 973-980
    • Choi, B.S.1    Alberti, D.B.2    Schelman, W.R.3    Kolesar, J.M.4    Thomas, J.P.5    Marnocha, R.6    Eickhoff, J.C.7    Ivy, S.P.8    Wilding, G.9    Holen, K.D.10
  • 133
    • 67649383518 scopus 로고    scopus 로고
    • Deferoxamine mimics the pattern of hypoxia-related injury at the microvasculature
    • Bartolome, S.; Dhillon, N.K.; Buch, S.; Casillan, A.J.; Wood, J.G.; O'Brien- Ladner, A.R., Deferoxamine mimics the pattern of hypoxia-related injury at the microvasculature. Shock, 2009, 31(5), 481-485.
    • (2009) Shock , vol.31 , Issue.5 , pp. 481-485
    • Bartolome, S.1    Dhillon, N.K.2    Buch, S.3    Casillan, A.J.4    Wood, J.G.5    O'Brien-Ladner, A.R.6
  • 134
    • 0036667557 scopus 로고    scopus 로고
    • A novel iron chelator that does not induce HIF-1 activity
    • Creighton-Gutteridge, M.; Tyrrell, R.M., A novel iron chelator that does not induce HIF-1 activity. Free Radic Biol Med, 2002, 33(3), 356-363.
    • (2002) Free Radic Biol Med , vol.33 , Issue.3 , pp. 356-363
    • Creighton-Gutteridge, M.1    Tyrrell, R.M.2
  • 135
    • 0032711332 scopus 로고    scopus 로고
    • Reduction of ultraviolet light-induced oxidative stress by amino acid-based iron chelators
    • Kitazawa, M.; Iwasaki, K., Reduction of ultraviolet light-induced oxidative stress by amino acid-based iron chelators. Biochim Biophys Acta, 1999, 1473(2-3), 400-408.
    • (1999) Biochim Biophys Acta , vol.1473 , Issue.2-3 , pp. 400-408
    • Kitazawa, M.1    Iwasaki, K.2
  • 136
    • 42549147608 scopus 로고    scopus 로고
    • Phase i study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia
    • Odenike, O.M.; Larson, R.A.; Gajria, D.; Dolan, M.E.; Delaney, S.M.; Karrison, T.G.; Ratain, M.J.; Stock, W., Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Invest New Drugs, 2008, 26(3), 233-239.
    • (2008) Invest New Drugs , vol.26 , Issue.3 , pp. 233-239
    • Odenike, O.M.1    Larson, R.A.2    Gajria, D.3    Dolan, M.E.4    Delaney, S.M.5    Karrison, T.G.6    Ratain, M.J.7    Stock, W.8
  • 138
    • 33947213058 scopus 로고    scopus 로고
    • Methemoglobinemia
    • Camp, N.E., Methemoglobinemia. J Emerg Nurs, 2007, 33(2), 172-174.
    • (2007) J Emerg Nurs , vol.33 , Issue.2 , pp. 172-174
    • Camp, N.E.1
  • 139
    • 74549133551 scopus 로고    scopus 로고
    • Biopreservation of red blood cells - The struggle with hemoglobin oxidation
    • Kanias, T.; Acker, J.P., Biopreservation of red blood cells - the struggle with hemoglobin oxidation. FEBS J, 2010, 277(2), 343-356.
    • (2010) FEBS J , vol.277 , Issue.2 , pp. 343-356
    • Kanias, T.1    Acker, J.P.2
  • 140
    • 0015502066 scopus 로고
    • The generation of superoxide radical during the autoxidation of hemoglobin
    • Misra, H.P.; Fridovich, I., The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem, 1972, 247(21), 6960-6962.
    • (1972) J Biol Chem , vol.247 , Issue.21 , pp. 6960-6962
    • Misra, H.P.1    Fridovich, I.2
  • 141
    • 0035027754 scopus 로고    scopus 로고
    • Severe methemoglobinemia on reexposure to benzocaine
    • Udeh, C.; Bittikofer, J.; Sum-Ping, S.T., Severe methemoglobinemia on reexposure to benzocaine. J Clin Anesth, 2001, 13(2), 128-130.
    • (2001) J Clin Anesth , vol.13 , Issue.2 , pp. 128-130
    • Udeh, C.1    Bittikofer, J.2    Sum-Ping, S.T.3
  • 143
    • 15044364497 scopus 로고    scopus 로고
    • Aniline derivative-induced methemoglobin in rats
    • Singh, H.; Purnell, E.T., Aniline derivative-induced methemoglobin in rats. J Environ Pathol Toxicol Oncol, 2005, 24(1), 57-65.
    • (2005) J Environ Pathol Toxicol Oncol , vol.24 , Issue.1 , pp. 57-65
    • Singh, H.1    Purnell, E.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.